159 related articles for article (PubMed ID: 1865630)
21. Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
Carlsson L; Abrahamsson T
Eur J Pharmacol; 1989 Jul; 166(2):157-64. PubMed ID: 2792189
[TBL] [Abstract][Full Text] [Related]
22. [Are the radical scavenging properties of ACE inhibitors with sulfhydryl groups in therapeutically effective concentrations of quantitative significance?].
Becker BF; Reinholz N; Leipert B; Raschke P; Gerlach E
Klin Wochenschr; 1991; 69 Suppl 24():6-9. PubMed ID: 1650863
[TBL] [Abstract][Full Text] [Related]
23. Cardioprotective effects of the aminopeptidase P inhibitor apstatin: studies on ischemia/reperfusion injury in the isolated rat heart.
Erşahin C; Euler DE; Simmons WH
J Cardiovasc Pharmacol; 1999 Oct; 34(4):604-11. PubMed ID: 10511138
[TBL] [Abstract][Full Text] [Related]
24. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
[TBL] [Abstract][Full Text] [Related]
25. Myocardial protection by the nitroderivative of aspirin, NCX 4016: in vitro and in vivo experiments in the rabbit.
Rossoni G; Berti M; Colonna VD; Bernareggi M; Del Soldato P; Berti F
Ital Heart J; 2000 Feb; 1(2):146-55. PubMed ID: 10730616
[TBL] [Abstract][Full Text] [Related]
26. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts.
Linz W; Schölkens BA; Han YF
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S91-9. PubMed ID: 2438498
[TBL] [Abstract][Full Text] [Related]
28. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
Linz W; Wiemer G; Schölkens BA
Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
[TBL] [Abstract][Full Text] [Related]
29. [Possibilities of ACE inhibitor therapy in acute myocardial ischemia].
Ertl G; Bauer B; Gaudron P; Neubauer S; Schorb W; Kochsiek K
Klin Wochenschr; 1991; 69 Suppl 24():10-7; discussion 18-9. PubMed ID: 1865631
[TBL] [Abstract][Full Text] [Related]
30. Effects of endothelin on isolated ischaemic rat hearts during ramiprilat, bradykinin and indomethacin perfusion.
Linz W; Albus U; Schölkens BA
J Hypertens Suppl; 1989 Dec; 7(6):S310-1. PubMed ID: 2698945
[TBL] [Abstract][Full Text] [Related]
31. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts.
Linz W; Wiemer G; Schölkens BA
J Mol Cell Cardiol; 1992 Aug; 24(8):909-19. PubMed ID: 1331474
[TBL] [Abstract][Full Text] [Related]
32. Direct effects of the angiotensin-converting enzyme inhibitor ramiprilat on adult rat ventricular cardiomyocytes.
Helmig S; Schuckenböhmer P; Heger J; Euler G; Piper HM; Schlüter KD
Acta Physiol (Oxf); 2007 Dec; 191(4):267-74. PubMed ID: 17825088
[TBL] [Abstract][Full Text] [Related]
33. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological interference with the cardiac renin-angiotensin system.
Becker RH; Linz W; Schölkens BA
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S10-5. PubMed ID: 2483422
[TBL] [Abstract][Full Text] [Related]
35. The effects of bradykinin and the ischemic isolated rat heart.
Tio RA; van Gilst WH; Rett K; Wolters K; Dietze GJ; Wesseling H
Horm Metab Res Suppl; 1990; 22():85-9. PubMed ID: 2167866
[TBL] [Abstract][Full Text] [Related]
36. The cardioprotective effect of dual metallopeptidase inhibition: respective roles of endogenous kinins and natriuretic peptides.
Dumoulin MJ; Adam A; Burnett J; Heublein D; Yamaguchi N; Lamontagne D
Can J Physiol Pharmacol; 2005 Feb; 83(2):166-73. PubMed ID: 15791290
[TBL] [Abstract][Full Text] [Related]
37. Cardioprotective actions of bradykinin in myocardial ischemia and left ventricular hypertrophy.
Linz W; Wiemer G; Schölkens BA
Braz J Med Biol Res; 1994 Aug; 27(8):1949-54. PubMed ID: 7749386
[TBL] [Abstract][Full Text] [Related]
38. Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats.
Rochetaing A; Chapon C; Marescaux L; Le Bouil A; Furber A; Kreher P
Can J Physiol Pharmacol; 2003 Sep; 81(9):864-72. PubMed ID: 14614522
[TBL] [Abstract][Full Text] [Related]
39. Inhibitors of bradykinin-inactivating enzymes decrease myocardial ischemia/reperfusion injury following 3 and 7 days of reperfusion.
Schriefer JA; Broudy EP; Hassen AH
J Pharmacol Exp Ther; 2001 Sep; 298(3):970-5. PubMed ID: 11504792
[TBL] [Abstract][Full Text] [Related]
40. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
Wolfrum S; Richardt G; Dominiak P; Katus HA; Dendorfer A
Br J Pharmacol; 2001 Sep; 134(2):370-4. PubMed ID: 11564655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
